Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Kronos Bio Inc (NASDAQ: KRON) was $0.69 for the day, up 0.10% from the previous closing price of $0.69. In other words, the price has increased by $0.10 from its previous closing price. On the day, 0.43 million shares were traded. KRON stock price reached its highest trading level at $0.69 during the session, while it also had its lowest trading level at $0.6752.
Ratios:
Our analysis of KRON’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.93 and its Current Ratio is at 12.93. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.26.
On November 14, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $6 to $1.
On September 14, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $12.Berenberg initiated its Buy rating on September 14, 2022, with a $12 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 27 ’24 when BISCHOFBERGER NORBERT W bought 410,848 shares for $1.17 per share. The transaction valued at 478,843 led to the insider holds 10,597,468 shares of the business.
BISCHOFBERGER NORBERT W bought 204,670 shares of KRON for $254,957 on Jun 28 ’24. The PRESIDENT & CEO now owns 10,802,138 shares after completing the transaction at $1.25 per share. On Jun 10 ’24, another insider, BISCHOFBERGER NORBERT W, who serves as the PRESIDENT & CEO of the company, bought 1,378,901 shares for $0.88 each. As a result, the insider paid 1,208,469 and bolstered with 5,749,395 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KRON now has a Market Capitalization of 41989488 and an Enterprise Value of -33655504. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.57 while its Price-to-Book (P/B) ratio in mrq is 0.53. Its current Enterprise Value per Revenue stands at -3.661 whereas that against EBITDA is 0.685.
Stock Price History:
The Beta on a monthly basis for KRON is 1.68, which has changed by -0.087417245 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, KRON has reached a high of $1.60, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -14.25%, while the 200-Day Moving Average is calculated to be -25.73%.
Shares Statistics:
KRON traded an average of 479.43K shares per day over the past three months and 965930 shares per day over the past ten days. A total of 60.97M shares are outstanding, with a floating share count of 39.42M. Insiders hold about 35.34% of the company’s shares, while institutions hold 22.98% stake in the company. Shares short for KRON as of 1745971200 were 671404 with a Short Ratio of 1.40, compared to 1743379200 on 611610. Therefore, it implies a Short% of Shares Outstanding of 671404 and a Short% of Float of 1.4400001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
